Falloon J - Search Results

1

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

Connors M, Kovacs JA, Krevat S, Gea-Banacloche JC, Sneller MC, Flanigan M, Metcalf JA, Walker RE, Falloon J, Baseler M, Feuerstein I, Masur H, Lane HC. Connors M, et al. Among authors: falloon j. Nat Med. 1997 May;3(5):533-40. doi: 10.1038/nm0597-533. Nat Med. 1997. PMID: 9142122

2

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

Lane HC, Davey V, Kovacs JA, Feinberg J, Metcalf JA, Herpin B, Walker R, Deyton L, Davey RT Jr, Falloon J, et al. Lane HC, et al. Among authors: falloon j. Ann Intern Med. 1990 Jun 1;112(11):805-11. doi: 10.7326/0003-4819-112-11-805. Ann Intern Med. 1990. PMID: 1971503 Clinical Trial.

3

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.

Lane HC, Falloon J, Walker RE, Deyton L, Kovacs JA, Masur H, Banks S, Kirk LE, Baseler MW, Salzman NP, et al. Lane HC, et al. Among authors: falloon j. Ann Intern Med. 1989 Jul 1;111(1):41-50. doi: 10.7326/0003-4819-111-1-41. Ann Intern Med. 1989. PMID: 2735626 Clinical Trial.

4

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

Kovacs JA, Vogel S, Albert JM, Falloon J, Davey RT Jr, Walker RE, Polis MA, Spooner K, Metcalf JA, Baseler M, Fyfe G, Lane HC. Kovacs JA, et al. Among authors: falloon j. N Engl J Med. 1996 Oct 31;335(18):1350-6. doi: 10.1056/NEJM199610313351803. N Engl J Med. 1996. PMID: 8857018 Free article. Clinical Trial.

5

Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire.

Gea-Banacloche JC, Weiskopf EE, Hallahan C, López Bernaldo de Quirós JC, Flanigan M, Mican JM, Falloon J, Baseler M, Stevens R, Lane HC, Connors M. Gea-Banacloche JC, et al. Among authors: falloon j. J Infect Dis. 1998 Mar;177(3):579-85. doi: 10.1086/514233. J Infect Dis. 1998. PMID: 9498435

6

Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.

Walker RE, Carter CS, Muul L, Natarajan V, Herpin BR, Leitman SF, Klein HG, Mullen CA, Metcalf JA, Baseler M, Falloon J, Davey RT Jr, Kovacs JA, Polis MA, Masur H, Blaese RM, Lane HC. Walker RE, et al. Among authors: falloon j. Nat Med. 1998 Jul;4(7):852-6. doi: 10.1038/nm0798-852. Nat Med. 1998. PMID: 9662381

7

Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion.

Miller KD, Spooner K, Herpin BR, Rock-Kress D, Metcalf JA, Davey RT Jr, Falloon J, Kovacs JA, Polis MA, Walker RE, Masur H, Lane HC. Miller KD, et al. Among authors: falloon j. Clin Immunol. 2001 Apr;99(1):30-42. doi: 10.1006/clim.2001.5001. Clin Immunol. 2001. PMID: 11286539 Clinical Trial.

8

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.

Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, Metcalf JA, Sereti I, Polis MA, Davey RT, Tavel J, Falloon J, Stevens R, Lambert L, Dewar R, Schwartzentruber DJ, Anver MR, Baseler MW, Masur H, Dimitrov DS, Lane HC. Kovacs JA, et al. Among authors: falloon j. J Exp Med. 2001 Dec 17;194(12):1731-41. doi: 10.1084/jem.194.12.1731. J Exp Med. 2001. PMID: 11748275 Free PMC article.

9

Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.

Anthony KB, Yoder C, Metcalf JA, DerSimonian R, Orenstein JM, Stevens RA, Falloon J, Polis MA, Lane HC, Sereti I. Anthony KB, et al. Among authors: falloon j. J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):125-33. doi: 10.1097/00126334-200306010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12794543

10

A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.

Davey RT Jr, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC. Davey RT Jr, et al. Among authors: falloon j. J Infect Dis. 1991 Jul;164(1):43-52. doi: 10.1093/infdis/164.1.43. J Infect Dis. 1991. PMID: 1676045 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page